Genetic resistance to purine nucleoside phosphorylase inhibition in Plasmodium falciparum
- 12 February 2018
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 115 (9) , 2114-2119
Abstract
Plasmodium falciparum causes the most lethal form of human malaria and is a global health concern. The parasite responds to antimalarial therapies by developing drug resistance. The continuous development of new antimalarials with novel mechanisms of action is a priority for drug combination therapies. The use of transition-state analog inhibitors to block essential steps in purine salvage has been proposed as a new antimalarial approach. Mutations that reduce transition-state analog binding are also expected to reduce the essential catalytic function of the target. We have previously reported that inhibition of host and P. falciparum purine nucleoside phosphorylase ( Pf PNP) by DADMe-Immucillin-G (DADMe-ImmG) causes purine starvation and parasite death in vitro and in primate infection models. P. falciparum cultured under incremental DADMe-ImmG drug pressure initially exhibited increased Pf PNP gene copy number and protein expression. At increased drug pressure, additional Pf PNP gene copies appeared with point mutations at catalytic site residues involved in drug binding. Mutant Pf PNPs from resistant clones demonstrated reduced affinity for DADMe-ImmG, but also reduced catalytic efficiency. The catalytic defects were partially overcome by gene amplification in the region expressing Pf PNP. Crystal structures of native and mutated Pf PNPs demonstrate altered catalytic site contacts to DADMe-ImmG. Both point mutations and gene amplification are required to overcome purine starvation induced by DADMe-ImmG. Resistance developed slowly, over 136 generations (2 136 clonal selection). Transition-state analog inhibitors against Pf PNP are slow to induce resistance and may have promise in malaria therapy.Keywords
Funding Information
- HHS | National Institutes of Health (GM041916)
This publication has 35 references indexed in Scilit:
- Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policyMalaria Journal, 2013
- Mitotic Evolution of Plasmodium falciparum Shows a Stable Core Genome but Recombination in Antigen FamiliesPLOS Genetics, 2013
- Genome Wide Adaptations of Plasmodium falciparum in Response to Lumefantrine Selective Drug PressurePLOS ONE, 2012
- Plasmodium falciparum Parasites Are Killed by a Transition State Analogue of Purine Nucleoside Phosphorylase in a Primate Animal ModelPLOS ONE, 2011
- Artemisinin resistance in Plasmodium falciparum is associated with an altered temporal pattern of transcriptionBMC Genomics, 2011
- Piperaquine Resistance Is Associated with a Copy Number Variation on Chromosome 5 in Drug-Pressured Plasmodium falciparum ParasitesAntimicrobial Agents and Chemotherapy, 2011
- In vitro selection of Plasmodium falciparum drug-resistant parasite linesJournal of Antimicrobial Chemotherapy, 2009
- Geographic patterns of Plasmodium falciparum drug resistance distinguished by differential responses to amodiaquine and chloroquineProceedings of the National Academy of Sciences, 2009
- Artemisinin Resistance inPlasmodium falciparumMalariaNew England Journal of Medicine, 2009
- Qinghaosu (Artemisinin): The Price of SuccessScience, 2008